Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression (Q39544186)

https://doi.org/10.1016/j.ejca.2023.04.015

12 September 2017

1 reference

29 December 2023

title

Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression (English)

1 reference

12 September 2017

0 references

Tingting Lin

1

1 reference

12 September 2017

Zhiying Ding

2

1 reference

12 September 2017

Nan Li

3

1 reference

12 September 2017

Jiayun Xu

4

1 reference

12 September 2017

Guimin Luo

5

1 reference

12 September 2017

Junqiu Liu

6

1 reference

12 September 2017

Jiacong Shen

7

1 reference

12 September 2017

10 May 2011

1 reference

European Journal of Cancer

12 September 2017

1 reference

12 September 2017

47

1 reference

12 September 2017

1890-1907

1 reference

12 September 2017

12

1 reference

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

12 September 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

PBISe, a novel selenium-containing drug for the treatment of malignant melanoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Overexpression of phospholipid-hydroperoxide glutathione peroxidase in human dermal fibroblasts abrogates UVA irradiation-induced expression of interstitial collagenase/matrix metalloproteinase-1 by suppression of phosphatidylcholine hydroperoxide-m

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

On the potential of thioredoxin reductase inhibitors for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

The receptor for the cytotoxic ligand TRAIL

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

The molecular mechanism of protecting cells against oxidative stress by 2-selenium-bridged beta-cyclodextrin with glutathione peroxidase activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Cancer and the cell cycle

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

A unified model for apical caspase activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

The TRAIL to targeted therapy of breast cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Ebselen, a selenoorganic compound as glutathione peroxidase mimic

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Effect of 2-TeCD on the expression of adhesion molecules in human umbilical vein endothelial cells under the stimulation of tumor necrosis factor-alpha

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

A bis-cyclodextrin diselenide with glutathione peroxidase-like activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Aryl thiol substrate 3-carboxy-4-nitrobenzenethiol strongly stimulating thiol peroxidase activity of glutathione peroxidase mimic 2, 2'-ditellurobis(2-deoxy-beta-cyclodextrin).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

A novel glutathione peroxidase mimic with antioxidant activity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.EJCA.2011.04.004

Identifiers

DOI

10.1016/J.EJCA.2011.04.004

1 reference

12 September 2017

1 reference